![<?echo $_SERVER['SERVER_NAME'];?>](/template/twentyseventeen/skin/images/header.jpg)
Large-scale projects are under construction in Hubei and other places, producing a new generation of products with strong demand
Hubei and Shanghai will soon form two major domestic production bases for amino acids. Jilin Province will form a new amino acid production base in Northeast China. Anlitai Pharmaceutical Co., Ltd. will become the largest amino acid production base in southwest China. According to the Fine Chemicals Program of the Chinese Chemical Society. According to the latest statistics of the committee, during the “Eleventh Five-Year Plan†period, the international image of China’s small-scale amino acid industry with few varieties and poor quality is expected to be refreshed.
It is understood that in recent years, international medicine, food, feed and other industries have developed rapidly, and the demand for amino acids is increasing. This product has become one of China's important fine chemical export products. According to statistics, the total output of pharmaceutical-grade amino acids in China has exceeded 4,000 tons, a net increase of 8 times from the 1980s. From the perspective of output, China has become a world’s largest producer of amino acids, exporting more than 100,000 tons of amino acids annually, and exports in 2006 increased by 55.96% year-on-year. However, judging from the scale and varieties of enterprises, China still lags behind developed countries such as Japan, Germany, the United States, and France. First, the domestic manufacturers of amino acid raw material drugs are generally small in scale. Some manufacturers produce only a few hundred kilograms per year, and the products are monotonous. Second, the product structure is irrational. Some manufacturers have similar amino acid products. Third, products lack international competition. force. Only glutamic acid, with its huge annual output of more than 1.1 million tons from more than 30 manufacturers and low production costs, has a place in the international market. No domestic companies can compete with international companies such as Ajinomoto, BASF, and ADM in the United States.
According to the Technical Committee of the Fine Chemicals of the Chinese Chemical Society, during the "11th Five-Year Plan" period, China's fine chemical industry aims to develop and expand a new generation of products with strong market demand. As the two major domestically supported amino acid production bases, Hubei Hafeng Pharmaceutical Group cooperates with Wuhan University, and Shanghai cooperates with major Japanese companies to launch a long-term amino acid product line that is in short supply in the market. The nation's largest amino acid company, which is built with the investment of 800 million yuan in Hong Kong, will become a new amino acid production base in Northeast China. Anlitai Pharmaceutical Co., Ltd., a joint venture between Germany and France and Nanning, Guangxi, will become the largest pharmaceutical amino acid production base in Southwest China. After the above production lines are successively put into production, China's amino acid industry will undergo a qualitative leap in the “Eleventh Five-Year Plan†period, and it is expected to become a world’s largest producer of amino acids with both quality and scale.
Hubei and Shanghai will soon form two major domestic production bases for amino acids. Jilin Province will form a new amino acid production base in Northeast China. Anlitai Pharmaceutical Co., Ltd. will become the largest amino acid production base in southwest China. According to the Fine Chemicals Program of the Chinese Chemical Society. According to the latest statistics of the committee, during the “Eleventh Five-Year Plan†period, the international image of China’s small-scale amino acid industry with few varieties and poor quality is expected to be refreshed.
It is understood that in recent years, international medicine, food, feed and other industries have developed rapidly, and the demand for amino acids is increasing. This product has become one of China's important fine chemical export products. According to statistics, the total output of pharmaceutical-grade amino acids in China has exceeded 4,000 tons, a net increase of 8 times from the 1980s. From the perspective of output, China has become a world’s largest producer of amino acids, exporting more than 100,000 tons of amino acids annually, and exports in 2006 increased by 55.96% year-on-year. However, judging from the scale and varieties of enterprises, China still lags behind developed countries such as Japan, Germany, the United States, and France. First, the domestic manufacturers of amino acid raw material drugs are generally small in scale. Some manufacturers produce only a few hundred kilograms per year, and the products are monotonous. Second, the product structure is irrational. Some manufacturers have similar amino acid products. Third, products lack international competition. force. Only glutamic acid, with its huge annual output of more than 1.1 million tons from more than 30 manufacturers and low production costs, has a place in the international market. No domestic companies can compete with international companies such as Ajinomoto, BASF, and ADM in the United States.
According to the Technical Committee of the Fine Chemicals of the Chinese Chemical Society, during the "11th Five-Year Plan" period, China's fine chemical industry aims to develop and expand a new generation of products with strong market demand. As the two major domestically supported amino acid production bases, Hubei Hafeng Pharmaceutical Group cooperates with Wuhan University, and Shanghai cooperates with major Japanese companies to launch a long-term amino acid product line that is in short supply in the market. The nation's largest amino acid company, which is built with the investment of 800 million yuan in Hong Kong, will become a new amino acid production base in Northeast China. Anlitai Pharmaceutical Co., Ltd., a joint venture between Germany and France and Nanning, Guangxi, will become the largest pharmaceutical amino acid production base in Southwest China. After the above production lines are successively put into production, China's amino acid industry will undergo a qualitative leap in the “Eleventh Five-Year Plan†period, and it is expected to become a world’s largest producer of amino acids with both quality and scale.
Steel Flat Cross Arm Braces
1.Cross arm is an important part of the tower, its role is to install insulators and fittings, to support the wire, grounding wire, and make it as required to maintain a safe distance.
2. The full set can be with bolt and nut,etc.
3. Technical requirements:
4. Auto-cutter & puncher
5. No crack and No zinc leakage.
6. The zinc coating average thickness is 86 micron, can be up to >100 micron, or as your requirement.
7. All types and specifications is available.
8. Accept custimized types and sizes.
Steel Flat Cross Arm Braces
Steel Flat Cross Arm Braces,Galvanized Flat Steel Cross Arm Brace,Galvanized Steel Cross Arm,Cross Arm V Braces
Hebei Fangyu Trade Co., Ltd. , https://www.filtersmaterial.com